SCHEMBL4467990

SCHEMBL4467990

O=C1OCCc2ccnc(-c3ccccc3O)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
RAB9A P51151 2/20 0.35
THRB P10828 1/20 0.35
MAPKAPK2 P49137 1/20 0.34
MIF P14174 2/20 0.33
PABPC1 P11940 1/20 0.33
ALDH1A1 P00352 2/20 0.33
IDO1 P14902 1/20 0.33
MAPT P10636 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CTSL P07711 1/20 0.32
PTPRC P08575 1/20 0.32
CTSS P25774 1/20 0.32
PTPN13 Q12923 1/20 0.32
PDE10A Q9Y233 1/20 0.32
NPC1 O15118 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4750519 0.77 KDM4E (0.43) MAOBMAOAALDH1A1MAPTL3MBTL1
SCHEMBL9959163 0.72 MAOA (0.53) MAOBMAOARAB9ATHRBMIF
SCHEMBL23566352 0.71 NOS3 (0.41) MAOBMAOAALDH1A1
SCHEMBL19153122 0.71 MAOA (0.41) MAOBMAOAALDH1A1KDM4E
SCHEMBL8288513 0.71 MAOA (0.35) MAOBMAOAALDH1A1
SCHEMBL18238925 0.68 MAOA (0.36) MAOBMAOA
SCHEMBL4083689 0.67 ALDH1A1 (0.52) RAB9ATHRBALDH1A1IDO1MAPT
SCHEMBL23566351 0.66 HSP90AA1 (0.35) MAOBMAOAALDH1A1
SCHEMBL11488220 0.65 ANPEP (0.40) MAOBMAOAALDH1A1
SCHEMBL4474329 0.65 MAOA (0.33) MAOBMAOAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601736-B2 Such as 3,4-dihydro-pyrano[3,4-c]pyridine-1-on; cytokine suppressive antiinflammatory drugs; analgesics SK CHEMICALS CO., LTD. (KR) 2009-10-13 US claimed
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same SK CHEMICALS CO., LTD. (KR) 2007-11-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same IL5, IL1B, P2RY4 MAOB 760/4885MAOA 662/4885RAB9A 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.